Key result
PACS1 disorder is linked to high congenital heart disease rates, but shows normal global longitudinal strain.
Why the study?
Heart disease is frequently present in PACS1 neurodevelopmental disorder, but a comprehensive review of these anomalies and an evaluation of cardiac function in a patient cohort were lacking.
Observational (n=11)
Patients with PACS1-NDD have a high prevalence of structural heart disease, including newly reported ascending aortic dilatation and mitral valve prolapse, but demonstrate preserved myocardial strain, supporting the need for routine cardiological evaluation.
Supports screening consideration in PACS1-NDD; small cohort leaves open functional trajectory and generalizability.
Background: PACS1 neurodevelopmental disorder (PACS1-NDD) (MIM# 615009) is a rare autosomal dominant disease characterized by neurodevelopmental delay, dysmorphic facial features, and congenital malformations. Heart disease (HD) is frequently present in individuals with PACS1-NDD, but a compressive review of these anomalies and an evaluation of cardiac function in a cohort of patients are lacking. Methods: (i) Cardiac evaluation in 11 PACS1-NDD patients was conducted using conventional echocardiography. (ii) Heart function was assessed by tissue Doppler imaging, and two-dimensional speckle tracking was performed in seven patients and matched controls. (iii) This systematic review focused on determining HD prevalence in individuals with PACS1-NDD. Results: In our cohort, 7 of 11 patients presented HD. (Among them, three cases of ascending aortic dilatation (AAD) were detected and one mitral valve prolapse (MVP).) None of the patients showed echocardiographic pathological values, and the left global longitudinal strain was not significantly different between patients and controls (patients −24.26 ± 5.89% vs. controls −20.19 ± 1.75%, p = 0.3176). In the literature review, almost 42% (42/100) of individuals with PACS1-NDD reportedly experienced HD. Septal defects were the most common malformation, followed by patent ductus arteriosus. Conclusions: Our results show a high prevalence of HD in PACS1-NDD patients; in this way, AAD and MVP are reported for the first time in this syndrome. Furthermore, a detailed cardiac function evaluation in our cohort did not reveal evidence of cardiac dysfunction in individuals with PACS1-NDD. Cardiology evaluation should be included for all individuals with Schuurs-Hoeijmakers syndrome.
No takes yet. Share an insight, caveat, or question.
Latorre et al. (2023) conducted an observational in PACS1 neurodevelopmental disorder (Schuurs-Hoeijmakers syndrome) (n=11). PACS1 neurodevelopmental disorder vs. Matched healthy controls was evaluated on Left ventricular global longitudinal strain (p=0.3176). PACS1 neurodevelopmental disorder is associated with a high prevalence of congenital heart disease (63.6%), but left global longitudinal strain was not significantly different from healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: